ACO Name and Location:

Community Care Partnership of Maine (CCPM) 103 Maine Avenue Bangor, ME  04401

ACO Primary Contact:

Mary Prybylo 360 Broadway Bangor, ME 04401 (207) 907-1000 mary.prybylo@sjhhealth.com

Organizational Information:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
St. Joseph Hospital/St. Joseph’s Healthcare N
Millinocket Regional Hospital N
Pines Health Services N
Fish River Rural Health N
Penobscot Community Health Center/Penobscot Community Health Care N
City Of Caribou/Cary Medical Center N
Sebasticook Family Doctors/Hometown Health Center N
York County Community Action Corp/Nasson Health Care N
St. Joseph Ambulatory Care Inc. N
Katahdin Valley Health Center N
DFD Russell Medical Center, Inc. N
Portland Community Health Center/Greater Portland Health N

ACO Governing body:

Member Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Doody Kris CEO 1 Vote ACO Participant City of Caribou/Cary Medical Center
Pelletier Heather CEO, Chair 1 Vote ACO Participant Fish River Rural Health
Tucker Ann CEO 1 Vote ACO Participant Portland Community Health Center/Greater Portland Health
Winslow Robin CEO 1 Vote ACO Participant Hometown Health Center/Sebasticook Family Doctors
Humphrey Claudette CEO 1 Vote ACO Participant Katahdin Valley Health Center
Peterson Robert CEO 1 Vote ACO Participant Millinocket Regional Hospital
Sabol Martin Director of Health Services, Treasurer 1 Vote ACO Participant York County Community Action Corp/Nasson Health Care
Dwyer Lori Pres. & CEO 1 Vote ACO Participant Penobscot Community Health Center/Penobscot Community Health Care
Davis Jim CEO 1 Vote ACO Participant Pines Health Services
Prybylo Mary Pres. & CEO, CCPM CEO 1 Vote ACO Participant St. Joseph’s Hospital/St. Joseph’s Healthcare
Kane-Lewis Laurie CEO 1 Vote ACO Participant DFD Russell Medical Center, Inc.
Bovard Sandy 1 Vote Medicare Beneficiary Representative

Key ACO Clinical and Administrative Leadership:

Mary Prybylo ACO Executive
David Koffman Medical Director
Lori Dwyer Compliance Officer
Theresa Knowles Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Quality and Clinical Integration Committee David Koffman, MD, Chair; Theresa Knowles, FNP-C, Co-Chair
Data/IT Committee Sharyl White, Chair, HIPAA Security Officer
Medication Use Committee Felicity Homsted, PharmD, BCPS, Chair; Mark Miller, Co-Chair
Care Coordination Committee Angela Fileccia, MSW, Chair
Finance & Operations Committee Martin Sabol, Chair
Compliance Committee Lori Dwyer, Esq., Chair

Types of ACO Participants that form the ACO:

  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals
  • Critical Access Hospital (CAH) billing under Method II
  • Federally Qualified Health Center (FQHC)
  • Rural Health Clinic (RHC)

Shared Savings and Losses

Amount of Shared Savings and Losses:

First Agreement Period

  • Performance Year 2016, $2,130,758

Shared Savings Distribution:

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 50%

Quality Performance Results:

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 80.09 80.51
ACO-2 CAHPS: How Well Your Providers Communicate 92.66 93.01
ACO-3 CAHPS: Patients’ Rating of Provider 90.89 92.25
ACO-4 CAHPS: Access to Specialists 81.76 83.49
ACO-5 CAHPS: Health Promotion and Education 64.40 60.32
ACO-6 CAHPS: Shared Decision Making 77.74 75.40
ACO-7 CAHPS: Health Status/Functional Status 73.50 72.30
ACO-34 CAHPS: Stewardship of Patient Resources 28.99 26.97
ACO-8 Risk Standardized, All Condition Readmission 15.21 14.70
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 19.25 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 65.35 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 99.74 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 79.49 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 8.97 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 16.99 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 97.09 82.72
ACO-39 Documentation of Current Medications in the Medical Record 93.45 87.54
ACO-13 Falls: Screening for Future Fall Risk 72.82 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 73.36 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 86.43 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 79.31 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.24 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 81.42 53.63
ACO-19 Colorectal Cancer Screening 72.58 61.52
ACO-20 Breast Cancer Screening 83.78 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 61.45 76.79
ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease 82.40 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 12.01 18.24
ACO-41 Diabetes: Eye Exam 62.19 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 71.68 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 90.81 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 77.27 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 74.35 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Community Care Partnership of Maine, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A65119 in the public use files on data.cms.gov.

Payment Rule Waivers:

No, our ACO does not use the SNF 3-Day Rule Waiver.